Z
Ma, Zhigang, Harbin Eye Hospital, Harbin 150010, Heilongjiang Province, China
Y
Madney, Yasmin M, Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt
R
Mahmoud, Rania AA, Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt
P
Malakuti, Parnian, Faculty of Medicine, Szeged University of Medical Sciences, Szeged, Hungary
J
Mao, Junjun, Department of Pharmacy, The First Affiliated Hospital of Xi’an Medical University, Xi’an 710077, Shaanxi Province, China
T
Mao, Tie, Heilongjiang Provincial Hospital, Harbin 150036, Heilongjiang Province, China
X
Mao, Xiaoyan
Y
Mao, Yu, Department of Endocrinology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, Henan Province, China
F
Mehrabadi, Fahimeh Yarpour, Infection Control & Hand Hygiene Research Center, Imam Reza Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Meng, Ting-ting
B
Meng, Bobo, Department of Endocrinology, Affiliated Hospital of Hebei University, Baoding 71000, Hebei Province, China
J
Meng, Jia, Affiliated Hospital of Hebei University, Baoding 071000, Hebei Province, China
Meng, Jie , Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, Chinaa
Meng, Jun
L
Meng, Lin
X
Meng, Xianlan
Y
Meng, Yajuan, Ning County Maternal and Child Health Hospital, Qingyang 745200, Gansu Province, China
Meng, Yanan, Department of Clinical Laboratory, Affiliated Hospital of Hebei University, Baoding 071000, Hebei Province, China
S
Miao, Shimin
Miao, Shuhang , Xinghua City People’s Hospital, Xinghua 225700, Jiangsu Province, China
X
Miao, Xiaona, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China
Y
Miao, Yudi , Department of Hematology, Shaanxi Provincial People's Hospital, Xi’an 710068, Shaanxi Province, China
Miao, Yudi , Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’an 710068, China
Miao, Yudi , Department of Hematology, Shaanxi Provincial People’s Hospital, Xi’an 710068, Shaanxi Province, China
Miao, Yudi , [1] Lu S, Yao J, Li S, et al., 2021, Two Cases of Acute Non-Lymphocytic Leukemia with PICALM-MLLT10 and Literature Review. Chongqing Medicine, 50(19): 3369–3374. [2] Gao W, Jiang M, Gao L, et al., 2021, Analysis of Factors Related to Treatment Failure of Acute Lymphoblastic Leukemia in Children. Chinese Journal of Experimental Hematology, 29(03): 661–668. [3] Bai D, Bai Y, Tian F, 2021, Expression and Significance of Long Non-Coding RNA Homeobox Gene A11 Antisense RNA in the Bone Marrow of Children with Acute Lymphoblastic Leukemia. Cancer Progress, 19(20): 2087–2090. [4] Cao X, Wei Z, Liu D, et al., 2021, Comparison of the Efficacy of Haplotype and Sibling Hematopoietic Stem Cell Transplantation in the Treatment of Acute T-Lymphoblastic Leukemia in Complete Remission. Chinese Journal of Hematology, 42(03): 210–216. [5] Cao X, Qiu L, Zhang J, et al., 2021, Clinical Analysis of 41 Cases of Relapsed Acute B Lymphocytic Leukemia After CART Sequential Secondary Allogeneic Hematopoietic Stem Cell Transplantation. Chinese Journal of Hematology, 42(04): 318–323. [6] Zhang L, 2021, Changes of Peripheral Blood T Lymphocyte Subsets in Acute Myeloid Leukemia and Its Clinical Significance. Capital Food and Medicine, 28(17): 20–21. [7] Wang D, Ding Y, Zhou G, et al., 2021, Expression and Clinical Significance of Programmed Death Molecule 1/Programmed Death-Ligand 1 in Childhood Acute Lymphoblastic Leukemia. Chinese Journal of Practical Pediatrics, 36(07): 525–528. [8] Wang X, Chang Y, Liu Y, et al., 2021, Comparison of the Prognostic Significance of Minimal Residual Disease in Patients with PH-Positive Acute B Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation by Multiparameter Flow Cytometry and Real-Time PCR. Chin J Hematology, 42(02): 116–123. [9] Wang Z, Li S, Sun Y, et al., 2021, Positive Minimal Residual Disease Indicates Poor Prognosis of Acute Lymphoblastic Leukemia Patients with Complete Remission 2 or Above Before Allogeneic Transplantation. Chinese Journal of Laboratory Medicine, 44(12): 1145–1152. [10] Peng Q, Zhu C, Liu G, et al., 2021, Study on the Expression Significance of QKI, OCT4 and Bcl-2 mRNA in Children with Acute Lymphoblastic Leukemia. Chinese Journal of Cancer Prevention and Treatment, 28(15): 1151–1156. [11] Li L, Wang M, Song Y, et al., 2021, Application Value of ALL Multi-Probe System in the Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia. Experimental and Laboratory Medicine, 39(02): 374–376. [12] Zhang X, Wang L, Tang B, et al., 2020, Pretreatment of Unrelated Umbilical Cord Blood Transplantation Without Antithymocyte Globulin for the Treatment of Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Follow-Up Evaluation of 306 Cases. Chinese Journal of Tissue Engineering Research, 24(31): 4986–4993. [13] Tang W, 2020, Analysis of the Relationship Between Adverse Reactions and Plasma Concentrations of High-Dose Methotrexate in the Treatment of Childhood Acute Lymphoblastic Leukemia. China Prescription Drugs, 18(12): 70–71. [14] Lv M, Jiang E, He Y, et al., 2020, Comparison of the Efficacy of Autologous and Sibling Hematopoietic Stem Cell Transplantation in the Treatment of Ph+ Acute Lymphoblastic Leukemia. Chinese Journal of Hematology, 41(05): 373–378. [15] Feng J, Zhang L, Cao X, et al., 2020, Treatment of Ph-Chromosome-Negative Adolescents and Young Adults with Acute Lymphoblastic Leukemia with a Similar Regimen for Children: A Single-Center Retrospective Study. Chinese Journal of Hematology, 41(05): 399–404.
1201 - 1225 of 2507 items
<< < 44 45 46 47 48 49 50 51 52 53 > >>